Literature DB >> 3281223

Lessons for human influenza from pathogenicity studies with ferrets.

H Smith1, C Sweet.   

Abstract

In research on influenza, little attention has been given to factors that determine the patterns of infection in human adults or infants and the severity of disease. Ferret influenza has been used to elucidate the following facets of pathogenicity that bear on these questions about human disease: the differential infectivity of virus strains for the upper respiratory tract (URT); the reasons for less severe infection of the lower respiratory tract (LRT) than of the URT; why pneumonia is rare; and why strains differ in the production of LRT infection. The origin of fever has been defined; viruses have been shown to differ in fever-producing components. Poor spread of virus from the respiratory tract to other susceptible tissues and rarity of fetal infection have been explained. Death in neonatal ferrets due to influenza with either a syndrome akin to cot death or viral pneumonia have been elucidated, and protection of the young by immunized mothers has been demonstrated.

Entities:  

Mesh:

Year:  1988        PMID: 3281223     DOI: 10.1093/clinids/10.1.56

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  49 in total

1.  CRISPR/Cas9-mediated genome engineering of the ferret.

Authors:  Zhaohui Kou; Qian Wu; Xiaochen Kou; Chonghai Yin; Hong Wang; Zhentao Zuo; Yan Zhuo; Antony Chen; Shaorong Gao; Xiaoqun Wang
Journal:  Cell Res       Date:  2015-11-13       Impact factor: 25.617

2.  Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.

Authors:  Crina Stavaru; Adrian Onu; Emilia Lupulescu; Catalin Tucureanu; Orhan Rasid; Ene Vlase; Cristin Coman; Iuliana Caras; Alina Ghiorghisor; Laurentiu Berbecila; Vlad Tofan; Richard A Bowen; Nicole Marlenee; Airn Hartwig; Helle Bielefeldt-Ohmann; Susan L Baldwin; Neal Van Hoeven; Thomas S Vedvick; Chuong Huynh; Michael K O'Hara; Diana L Noah; Christopher B Fox
Journal:  Hum Vaccin Immunother       Date:  2015-11-30       Impact factor: 3.452

3.  An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models.

Authors:  Ciaran D Scallan; Debora W Tingley; Jonathan D Lindbloom; James S Toomey; Sean N Tucker
Journal:  Clin Vaccine Immunol       Date:  2012-11-14

Review 4.  Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models.

Authors:  Jessica A Belser; Alissa M Eckert; Terrence M Tumpey; Taronna R Maines
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

Review 5.  Virulence determinants of pandemic influenza viruses.

Authors:  Donna M Tscherne; Adolfo García-Sastre
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

6.  Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.

Authors:  Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 7.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

8.  Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus.

Authors:  Erin M Sorrell; Hongquan Wan; Yonas Araya; Haichen Song; Daniel R Perez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

Review 9.  Animal models for the study of influenza pathogenesis and therapy.

Authors:  Dale L Barnard
Journal:  Antiviral Res       Date:  2009-01-25       Impact factor: 5.970

10.  The SARS-CoV ferret model in an infection-challenge study.

Authors:  Yong-Kyu Chu; Georgia D Ali; Fuli Jia; Qianjun Li; David Kelvin; Ronald C Couch; Kevin S Harrod; Julie A Hutt; Cheryl Cameron; Susan R Weiss; Colleen B Jonsson
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.